TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma
Biomedical Research - Japan
doi 10.2220/biomedres.41.53
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Biomedical Research Press